Skip to main content
. 2018 Jan 13;9(15):12250–12260. doi: 10.18632/oncotarget.24242

Figure 6. 7A7 does not affect tumour growth in vivo.

Figure 6

Established TC-1 (AB) or HPV38 (CD) tumours were treated with PBS (i.v.) or 56ug of 7A7 (i.v.) or 7A7 Fc Silent (i.v.) every three days. (A, C) Tumour growth curves, and (B, D) survival curves. (A, B) n = 4-6 mice/group; (C–D) n = 4 mice/group. Data shown represent two independent experiments. (A-D) No statistical differences between groups.